BACKGROUND: Renal cell carcinoma (RCC) with tumor thrombus extension into the right atrium (level IV) is a rare life-threatening clinical condition that can only be managed by means of a combined urological and cardiac surgical approach. The early and late outcomes of this radical treatment were analyzed in a large single-institution series over a period of 30 years. METHODS: In 37 patients with RCC and intracardiac tumor thrombus extension, nephrectomy was performed followed by the extraction of the intracaval and intracardiac tumor thrombus under direct visual control during deep hypothermic circulatory arrest (DHCA). Recently, in 13 patients, selective aortic arch perfusion (SAAP) was instituted during DHCA. RESULTS: In all patients, precise removal of the tumor thrombus was accomplished in a bloodless field. The mean duration of isolated DHCA was 15 ± 6 min, and 31.5 ± 10.2 min in the case of DHCA + SAAP, at a mean hypothermia of 22.7 ± 4°C. In-hospital mortality was 7.9% (3 patients). In Kaplan-Meier analysis, the estimated median survival was 26.4 months whereas the 5-year cancer-related survival rate was 51%. CONCLUSIONS: Despite its complexity, this extensive procedure can be performed safely with a generally uneventful postoperative course. The use of cardiopulmonary bypass with DHCA, with the advantage of SAAP, allows for a safe, precise, and complete extirpation of intracaval and intracardiac tumor mass. Late outcomes after radical surgical treatment in patients with RCC and tumor thrombus reaching up in the right atrium in our series justify this extensive procedure.

Department of Cardiac Surgery Charles University Faculty of Medicine in Hradec Kralove and University Hospital in Hradec Kralove Czechia

Department of Urology Charles University Faculty of Medicine in Hradec Kralove and University Hospital in Hradec Kralove Czechia

The Fingerland Department of Pathology Charles University Faculty of Medicine in Hradec Kralove and University Hospital in Hradec Kralove Czechia

Zobrazit více v PubMed

Marshall FF, Reitz BA, Diamond DA. A new technique for management of renal cell carcinoma involving the right atrium: Hypothermia and cardiac arrest. J Urol. (1984) 131(1):103–7. doi: 10.1016/S0022-5347(17)50221-9 PubMed DOI

Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol. (1987) 59(5):390–5. doi: 10.1111/j.1464-410X.1987.tb04832.x PubMed DOI

Dominik J, Moravek P, Zacek P, Vojacek J, Brtko M, Podhola M, et al. . Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium. BJU Int (2013) 111(3 Pt B):E59–64. doi: 10.1111/j.1464-410X.2012.11515.x PubMed DOI

Zacek P, Dominik J, Brodak M, Louda M. Selective aortic arch perfusion enables to avoid deep hypothermic circulatory arrest for extirpation of renal cell carcinoma with tumour thrombus extension into the right atrium. Interact Cardiovasc Thorac Surg (2014) 18(4):411–4. doi: 10.1093/icvts/ivt545 PubMed DOI PMC

Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and Male genital organs-part a: Renal, penile, and testicular tumours. Eur Urol. (2016) 70(1):93–105. doi: 10.1016/j.eururo.2016.02.029 PubMed DOI

Chiappini B, Savini C, Marinelli G, Suarez SM, Di Eusanio M, Fiorani V, et al. . Cavoatrial tumor thrombus: single-stage surgical approach with profound hypothermia and circulatory arrest, including a review of the literature. J Thorac Cardiovasc Surg (2002) 124(4):684–8. doi: 10.1067/mtc.2002.124295 PubMed DOI

Granberg CF, Boorjian SA, Schaff HV, Orszulak TA, Leibovich BC, Lohse CM, et al. . Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass. Urology. (2008) 72(1):148–52. doi: 10.1016/j.urology.2008.01.006 PubMed DOI

Glazer AA, Novick AC. Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol. (1996) 155(2):448–50. doi: 10.1016/S0022-5347(01)66415-2 PubMed DOI

Shahian DM, Libertino JA, Zinman LN, Leonardi HK, Eyre RC. Resection of cavoatrial renal cell carcinoma employing total circulatory arrest. Arch Surg (1990) 125(6):727–31. doi: 10.1001/archsurg.1990.01410180045009 PubMed DOI

Vogt PR, Ensner R, Pretre R, Schmidli J, Reuthebuch O, Zund G, et al. . Less invasive surgical treatment of renal cell carcinomas extending into the right heart and pulmonary arteries: surgery for renal cell carcinoma. J Card Surg (1999) 14(5):330–3. doi: 10.1111/j.1540-8191.1999.tb01004.x PubMed DOI

Ciancio G, Shirodkar SP, Soloway MS, Livingstone AS, Barron M, Salerno TA. Renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass. Ann Thorac Surg (2010) 89(2):505–10. doi: 10.1016/j.athoracsur.2009.11.025 PubMed DOI

Onorati F, Santini F, Telesca M, Veraldi GF, Faggian G, Mazzucco A. Avoiding sternotomy and cardiopulmonary bypass in type IV renal carcinoma: is it really worth it? Ann Thorac Surg (2011) 91(2):640–1. doi: 10.1016/j.athoracsur.2010.07.049 PubMed DOI

Kim HY, Baek SH, Yoon JU, Lee DH, Byeon GJ, Ahn JH. Cardiac arrest during radical nephrectomy due to a mass in the right ventricular outflow tract. J Clin Anesth (2016) 33:156–9. doi: 10.1016/j.jclinane.2016.02.041 PubMed DOI

Ciancio G, Gonzalez J, Shirodkar SP, Angulo JC, Soloway MS. Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. Eur Urol. (2011) 59(3):401–6. doi: 10.1016/j.eururo.2010.07.028 PubMed DOI

Hevia V, Ciancio G, Gomez V, Alvarez S, Diez-Nicolas V, Burgos FJ. Surgical technique for the treatment of renal cell carcinoma with inferior vena cava tumor thrombus: Tips, tricks and oncological results. Springerplus. (2016) 5:132. doi: 10.1186/s40064-016-1825-1 PubMed DOI PMC

Souki FG, Demos M, Fermin L, Ciancio G. Transesophageal echocardiography-guided thrombectomy of intracardiac renal cell carcinoma without cardiopulmonary bypass. Ann Card Anaesth. (2016) 19(4):740–3. doi: 10.4103/0971-9784.191571 PubMed DOI PMC

Gaudino M, Lau C, Cammertoni F, Vargiu V, Gambardella I, Massetti M, et al. . Surgical treatment of renal cell carcinoma with cavoatrial involvement: A systematic review of the literature. Ann Thorac Surg (2016) 101(3):1213–21. doi: 10.1016/j.athoracsur.2015.10.003 PubMed DOI

Chopra S, Simone G, Metcalfe C, de Castro Abreu AL, Nabhani J, Ferriero M, et al. . Robot-assisted level II-III inferior vena cava tumor thrombectomy: Step-by-Step technique and 1-year outcomes. Eur Urol. (2017) 72(2):267–74. doi: 10.1016/j.eururo.2016.08.066 PubMed DOI PMC

Gill IS, Cacciamani GE, Duddalwar V, Thangathurai D, Cunningham M. Renal cancer with extensive level IV intracardiac tumour thrombus removed by robot. Lancet. (2020) 396(10262):e88. doi: 10.1016/S0140-6736(20)32291-1 PubMed DOI

Wang B, Huang Q, Liu K, Fan Y, Peng C, Gu L, et al. . Robot-assisted level III-IV inferior vena cava thrombectomy: Initial series with step-by-step procedures and 1-yr outcomes. Eur Urol. (2020) 78(1):77–86. doi: 10.1016/j.eururo.2019.04.019 PubMed DOI

Lardas M, Stewart F, Scrimgeour D, Hofmann F, Marconi L, Dabestani S, et al. . Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus. Eur Urol. (2016) 70(2):265–80. doi: 10.1016/j.eururo.2015.11.034 PubMed DOI

Rodriguez-Fernandez IA, Rodriguez-Romo L, Hernandez-Barajas D, Gonzalez-Conchas GA, Verdines-Perez A, Templeton AJ, et al. . Adjuvant radiation therapy after radical nephrectomy in patients with localized renal cell carcinoma: A systematic review and meta-analysis. Eur Urol Oncol (2019) 2(4):448–55. doi: 10.1016/j.euo.2018.10.003 PubMed DOI

Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas NB, et al. . Adjuvant vascular endothelial growth factor-targeted therapy in renal cell carcinoma: A systematic review and pooled analysis. Eur Urol. (2018) 74(5):611–20. doi: 10.1016/j.eururo.2018.05.002 PubMed DOI PMC

Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Ljungberg B, et al. . The 2022 updated European association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma. Eur Urol. (2023) 83(1):10–4. doi: 10.1016/j.eururo.2022.10.010 PubMed DOI

Choueiri TK, Powles T. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. Reply. N Engl J Med (2021) 385(20):1920. doi: 10.1056/NEJMoa2106391 PubMed DOI

Radical nephrectomy with inferior vena caval thrombectomy for level I to IV tumor thrombus: long-term single-center experience